BIOJAM HOLDING GROUP and PASCOE Pharmazeutische Präparate GmbH, two European pharmaceutical companies, recently announced a strengthening of their partnership on the European market.
BIOJAM, based in Portugal, and PASCOE, based in Germany, have chosen the city of Gießen, where PASCOE's headquarters are located, as the place to strengthen their business collaboration. The partnership between the two companies aims to develop and commercialise innovative pharmaceutical products to meet the needs of European patients in key areas such as burns, oncology, intensive care and surgery. With this agreement, BIOJAM and PASCOE believe they will increase their presence on the market and provide patients with access to innovative healthcare solutions of the highest quality standards on a daily basis.
